Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Lisinopril epimer

● Auf Lager

Katalog-Nr.::	VE009468
CAS-Nr.::	N/A
Summenformel::	C21H31N3O5
Molare Masse::	405.5 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu Lisinopril epimer

Parent drug

Lisinopril

IUPAC-Name

(R)-1-(L-Lysyl)-2-((R)-1-carboxy-3-phenylpropyl)pyrrolidine-2-carboxylic Acid

Pharmacopeial Synonyms

N/A

Other Synonyms

N/A

SMILES

O=C([C@@]1([C@H](C(O)=O)CCC2=CC=CC=C2)N(C([C@H](CCCCN)N)=O)CCC1)O

Inchl

InChI=1S/C21H31N3O5/c22-13-5-4-9-17(23)18(25)24-14-6-12-21(24,20(28)29)16(19(26)27)11-10-15-7-2-1-3-8-15/h1-3,7-8,16-17H,4-6,9-14,22-23H2,(H,26,27)(H,28,29)/t16-,17-,21+/m0/s1InChI=1S/C21H31N3O5/c22-13-5-4-9-17(23)18(25)24-14-6-12-21(24,20(28)29)16(19(26)27)11-10-15-7-2-1-3-8-15/h1-3,7-8,16-17H,4-6,9-14,22-23H2,(H,26,27)(H,28,29)/t16-,17-,21+/m0/s1

Beschreibung

The compound Lisinopril epimer is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Lisinopril production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.